Delivery Order SPE2DE24DA010-SPE2D626F56V1
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc.'s Abbott Vascular division was awarded a delivery order valued at $5,695 on December 11, 2025, under a Defense Logistics Agency Medical Supply Chain contract. This fixed-price delivery order with economic price adjustment authority is scheduled for completion by January 6, 2026, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. This delivery order represents a task order draw against Abbott's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $17,250 from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price contract with economic price adjustment provision will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. As a child entity of Abbott Laboratories Inc., Abbott...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F56V1Delivery Order
Abbott Laboratories Inc.'s Abbott Vascular Inc. division was awarded a $5,695.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on December 19, 2025, with an ultimate completion date of December 24, 2025. This delivery order, contract number 4570355453, represents work to be performed in Santa Clara, California and was awarded through full and open competition with no set-aside designation. The award follows Abbott Vascular's established role as a critical federal supplier of advanced cardiovascular medical technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, and other specialized surgical implants to military and veteran healthcare networks. This delivery order is issued under Abbott's broader relationship with the Defense Logistics Agency, which has awarded the company a substantial $117.1 million Indefinite Delivery Contract for comprehensive cardiovascular procedural packages covering devices, instrumentation, accessories, and related medical technologies. This underlying vehicle has generated numerous task orders throughout 2024 and 2025, positioning Abbott Vascular as an essential element of the federal government's medical supply infrastructure. Abbott's federal contracting portfolio demonstrates consistent competitive success across the Department of Veterans Affairs, Defense Logistics Agency, Department of Defense, and other federal healthcare agencies, with contract values historically ranging from modest task orders to comprehensive procurement vehicles exceeding several hundred thousand dollars.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/18/25 |